Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes (FAMOUS NSTEMI)
A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve (FFR) Measurement Versus Management Guided by Coronary Angiography Alone(Standard Care) in Patients With Non-ST Elevation MI.
Sponsor: Abbott Medical Devices
A PHASE4 clinical study on Myocardial Infarction and NonST Elevation Myocardial Infarction, this trial is ongoing. The trial is conducted by Abbott Medical Devices and has accumulated 10 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jul 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Feb 2019 — Jul 2020 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- British Heart Foundation
- NHS National Waiting Times Centre Board
- University of Glasgow
For direct contact, visit the study record on ClinicalTrials.gov .